ACELYRIN is currently recruiting for a clinical study designed to evaluate lonigutamab in subjects with TED. Use this link to learn more.
Immunovant is presently recruiting for a TED clinical research study. Please use this link to learn more.
See “Understanding Thyroid Eye Disease” contributed by Immunovant.
Lassen Therapeutics is currently recruiting for 2 clinical trials evaluating a novel treatment for people with TED.
Phase 2 clinical trial exploring LASN01 as a potential treatment for people with active TED
Phase 1 clinical trial further exploring LASN01 in people with active TED or idiopathic pulmonary fibrosis (IPF)
Sling Therapeutics is now recruiting participants for a Phase 2b study to evaluate a new oral treatment for TED.